Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 15/20 | 0.60 |
| ▸ | TNKS2 | Q9H2K2 | 15/20 | 0.60 |
| ▸ | PARP1 | P09874 | 8/20 | 0.60 |
| ▸ | PARP2 | Q9UGN5 | 8/20 | 0.60 |
| ▸ | BRD4 | O60885 | 2/20 | 0.47 |
| ▸ | IL17A | Q16552 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30435018 | 0.91 | TNKS (0.61) | TNKSTNKS2PARP1PARP2BRD4 | |
| SCHEMBL120737 | 0.91 | TNKS (0.61) | TNKSTNKS2PARP1PARP2BRD4 | |
| SCHEMBL377657 | 0.84 | BRD4 (0.64) | TNKSTNKS2PARP1PARP2BRD4 | |
| SCHEMBL377714 | 0.83 | BRD4 (0.57) | PARP1BRD4IL17A | |
| SCHEMBL16516162 | 0.79 | TNKS (0.50) | TNKSTNKS2PARP1PARP2 | |
| SCHEMBL377744 | 0.78 | BRD4 (0.51) | TNKSTNKS2PARP1BRD4IL17A | |
| SCHEMBL378054 | 0.78 | KDM4E (0.53) | TNKSTNKS2PARP1BRD4IL17A | |
| SCHEMBL120735 | 0.77 | TNKS (0.54) | TNKSTNKS2PARP1PARP2 | |
| SCHEMBL15775361 | 0.76 | TNKS (1.00) | TNKSTNKS2PARP1PARP2 | |
| SCHEMBL1387257 | 0.76 | TNKS (1.00) | TNKSTNKS2PARP1PARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408454-B1 | NOVEL ANTI-INFLAMMATORY AGENTS | RESVERLOGIX CORP (CA) | 2024-07-24 | — | — | EP | disclosed |
| US-11407719-B2 | Anti-inflammatory agents | RESVERLOGIX CORP. (CA) | 2022-08-09 | — | — | US | disclosed |
| US-20210070716-A1 | ANTI-INFLAMMATORY AGENTS | HEPALINK (HONG KONG) LIMITED (HK) | 2021-03-11 | — | — | US | disclosed |
| US-10882828-B2 | Anti-inflammatory agents | RESVERLOGIX CORP. (CA) | 2021-01-05 | — | — | US | disclosed |
| US-20190119222-A1 | NOVEL ANTI-INFLAMMATORY AGENTS | RESVERLOGIX CORP. (CA) | 2019-04-25 | — | — | US | disclosed |
| US-10131640-B2 | Anti-inflammatory agents | RESVERLOGIX CORP. (CA) | 2018-11-20 | — | — | US | disclosed |
| US-20160137613-A1 | NOVEL ANTI-INFLAMMATORY AGENTS | RESVERLOGIX CORP. (CA) | 2016-05-19 | — | — | US | disclosed |
| US-9238640-B2 | Anti-inflammatory agents | RESVERLOGIX CORP. (CA) | 2016-01-19 | — | — | US | disclosed |
| US-20120040954-A1 | NOVEL ANTI-INFLAMMATORY AGENTS | HEPALINK (HONG KONG) LIMITED (HK) | 2012-02-16 | — | — | US | disclosed |
| EP-2408454-A2 | NOVEL ANTI-INFLAMMATORY AGENTS | RESVERLOGIX CORP. (CA) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010106436-A2 | NOVEL ANTI-INFLAMMATORY AGENTS | RESVERLOGIX CORP. (CA) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11407719-B2 | Anti-inflammatory agents | VCAM1, ICAM1, IL6 | TNKS 1152/4885TNKS2 1915/4885PARP1 1156/4885 |
| US-20160137613-A1 | NOVEL ANTI-INFLAMMATORY AGENTS | VCAM1, ICAM1, IL6 | TNKS 1051/4885TNKS2 1720/4885PARP1 1176/4885 |
| US-10882828-B2 | Anti-inflammatory agents | VCAM1, ICAM1, IL6 | TNKS 1152/4885TNKS2 1915/4885PARP1 1156/4885 |
| US-20210070716-A1 | ANTI-INFLAMMATORY AGENTS | VCAM1, ICAM1, IL6 | TNKS 1152/4885TNKS2 1915/4885PARP1 1156/4885 |
| US-10131640-B2 | Anti-inflammatory agents | VCAM1, ICAM1, IL6 | TNKS 1152/4885TNKS2 1915/4885PARP1 1156/4885 |
| US-20190119222-A1 | NOVEL ANTI-INFLAMMATORY AGENTS | VCAM1, ICAM1, IL6 | TNKS 1051/4885TNKS2 1720/4885PARP1 1176/4885 |
| US-20120040954-A1 | NOVEL ANTI-INFLAMMATORY AGENTS | VCAM1, ICAM1, IL6 | TNKS 1051/4885TNKS2 1720/4885PARP1 1176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.